Natural (dihydro)phenanthrene plant compounds are direct activators of AMPK through its allosteric drug and metabolite–binding site

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Natural (dihydro)phenanthrene plant compounds are direct activators of AMPK through its allosteric drug and metabolite–binding site. / Sanders, Matthew J.; Ratinaud, Yann; Neopane, Katyayanee; Bonhoure, Nicolas; Day, Emily A.; Ciclet, Olivier; Lassueur, Steve; Pinta, Martine Naranjo; Deak, Maria; Brinon, Benjamin; Christen, Stefan; Steinberg, Gregory R.; Barron, Denis; Sakamoto, Kei.

In: Journal of Biological Chemistry, Vol. 298, No. 5, 101852, 2022.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Sanders, MJ, Ratinaud, Y, Neopane, K, Bonhoure, N, Day, EA, Ciclet, O, Lassueur, S, Pinta, MN, Deak, M, Brinon, B, Christen, S, Steinberg, GR, Barron, D & Sakamoto, K 2022, 'Natural (dihydro)phenanthrene plant compounds are direct activators of AMPK through its allosteric drug and metabolite–binding site', Journal of Biological Chemistry, vol. 298, no. 5, 101852. https://doi.org/10.1016/j.jbc.2022.101852

APA

Sanders, M. J., Ratinaud, Y., Neopane, K., Bonhoure, N., Day, E. A., Ciclet, O., Lassueur, S., Pinta, M. N., Deak, M., Brinon, B., Christen, S., Steinberg, G. R., Barron, D., & Sakamoto, K. (2022). Natural (dihydro)phenanthrene plant compounds are direct activators of AMPK through its allosteric drug and metabolite–binding site. Journal of Biological Chemistry, 298(5), [101852]. https://doi.org/10.1016/j.jbc.2022.101852

Vancouver

Sanders MJ, Ratinaud Y, Neopane K, Bonhoure N, Day EA, Ciclet O et al. Natural (dihydro)phenanthrene plant compounds are direct activators of AMPK through its allosteric drug and metabolite–binding site. Journal of Biological Chemistry. 2022;298(5). 101852. https://doi.org/10.1016/j.jbc.2022.101852

Author

Sanders, Matthew J. ; Ratinaud, Yann ; Neopane, Katyayanee ; Bonhoure, Nicolas ; Day, Emily A. ; Ciclet, Olivier ; Lassueur, Steve ; Pinta, Martine Naranjo ; Deak, Maria ; Brinon, Benjamin ; Christen, Stefan ; Steinberg, Gregory R. ; Barron, Denis ; Sakamoto, Kei. / Natural (dihydro)phenanthrene plant compounds are direct activators of AMPK through its allosteric drug and metabolite–binding site. In: Journal of Biological Chemistry. 2022 ; Vol. 298, No. 5.

Bibtex

@article{00fc7f2ee44f42ad94d72266f94f4179,
title = "Natural (dihydro)phenanthrene plant compounds are direct activators of AMPK through its allosteric drug and metabolite–binding site",
abstract = "AMP-activated protein kinase (AMPK) is a central energy sensor that coordinates the response to energy challenges to maintain cellular ATP levels. AMPK is a potential therapeutic target for treating metabolic disorders, and several direct synthetic activators of AMPK have been developed that show promise in preclinical models of type 2 diabetes. These compounds have been shown to regulate AMPK through binding to a novel allosteric drug and metabolite (ADaM)–binding site on AMPK, and it is possible that other molecules might similarly bind this site. Here, we performed a high-throughput screen with natural plant compounds to identify such direct allosteric activators of AMPK. We identified a natural plant dihydrophenathrene, Lusianthridin, which allosterically activates and protects AMPK from dephosphorylation by binding to the ADaM site. Similar to other ADaM site activators, Lusianthridin showed preferential activation of AMPKβ1-containing complexes in intact cells and was unable to activate an AMPKβ1 S108A mutant. Lusianthridin dose-dependently increased phosphorylation of acetyl-CoA carboxylase in mouse primary hepatocytes, which led to a corresponding decrease in de novo lipogenesis. This ability of Lusianthridin to inhibit lipogenesis was impaired in hepatocytes from β1 S108A knock-in mice and mice bearing a mutation at the AMPK phosphorylation site of acetyl-CoA carboxylase 1/2. Finally, we show that activation of AMPK by natural compounds extends to several analogs of Lusianthridin and the related chemical series, phenanthrenes. The emergence of natural plant compounds that regulate AMPK through the ADaM site raises the distinct possibility that other natural compounds share a common mechanism of regulation.",
author = "Sanders, {Matthew J.} and Yann Ratinaud and Katyayanee Neopane and Nicolas Bonhoure and Day, {Emily A.} and Olivier Ciclet and Steve Lassueur and Pinta, {Martine Naranjo} and Maria Deak and Benjamin Brinon and Stefan Christen and Steinberg, {Gregory R.} and Denis Barron and Kei Sakamoto",
note = "Publisher Copyright: {\textcopyright} 2022 THE AUTHORS.",
year = "2022",
doi = "10.1016/j.jbc.2022.101852",
language = "English",
volume = "298",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology, Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - Natural (dihydro)phenanthrene plant compounds are direct activators of AMPK through its allosteric drug and metabolite–binding site

AU - Sanders, Matthew J.

AU - Ratinaud, Yann

AU - Neopane, Katyayanee

AU - Bonhoure, Nicolas

AU - Day, Emily A.

AU - Ciclet, Olivier

AU - Lassueur, Steve

AU - Pinta, Martine Naranjo

AU - Deak, Maria

AU - Brinon, Benjamin

AU - Christen, Stefan

AU - Steinberg, Gregory R.

AU - Barron, Denis

AU - Sakamoto, Kei

N1 - Publisher Copyright: © 2022 THE AUTHORS.

PY - 2022

Y1 - 2022

N2 - AMP-activated protein kinase (AMPK) is a central energy sensor that coordinates the response to energy challenges to maintain cellular ATP levels. AMPK is a potential therapeutic target for treating metabolic disorders, and several direct synthetic activators of AMPK have been developed that show promise in preclinical models of type 2 diabetes. These compounds have been shown to regulate AMPK through binding to a novel allosteric drug and metabolite (ADaM)–binding site on AMPK, and it is possible that other molecules might similarly bind this site. Here, we performed a high-throughput screen with natural plant compounds to identify such direct allosteric activators of AMPK. We identified a natural plant dihydrophenathrene, Lusianthridin, which allosterically activates and protects AMPK from dephosphorylation by binding to the ADaM site. Similar to other ADaM site activators, Lusianthridin showed preferential activation of AMPKβ1-containing complexes in intact cells and was unable to activate an AMPKβ1 S108A mutant. Lusianthridin dose-dependently increased phosphorylation of acetyl-CoA carboxylase in mouse primary hepatocytes, which led to a corresponding decrease in de novo lipogenesis. This ability of Lusianthridin to inhibit lipogenesis was impaired in hepatocytes from β1 S108A knock-in mice and mice bearing a mutation at the AMPK phosphorylation site of acetyl-CoA carboxylase 1/2. Finally, we show that activation of AMPK by natural compounds extends to several analogs of Lusianthridin and the related chemical series, phenanthrenes. The emergence of natural plant compounds that regulate AMPK through the ADaM site raises the distinct possibility that other natural compounds share a common mechanism of regulation.

AB - AMP-activated protein kinase (AMPK) is a central energy sensor that coordinates the response to energy challenges to maintain cellular ATP levels. AMPK is a potential therapeutic target for treating metabolic disorders, and several direct synthetic activators of AMPK have been developed that show promise in preclinical models of type 2 diabetes. These compounds have been shown to regulate AMPK through binding to a novel allosteric drug and metabolite (ADaM)–binding site on AMPK, and it is possible that other molecules might similarly bind this site. Here, we performed a high-throughput screen with natural plant compounds to identify such direct allosteric activators of AMPK. We identified a natural plant dihydrophenathrene, Lusianthridin, which allosterically activates and protects AMPK from dephosphorylation by binding to the ADaM site. Similar to other ADaM site activators, Lusianthridin showed preferential activation of AMPKβ1-containing complexes in intact cells and was unable to activate an AMPKβ1 S108A mutant. Lusianthridin dose-dependently increased phosphorylation of acetyl-CoA carboxylase in mouse primary hepatocytes, which led to a corresponding decrease in de novo lipogenesis. This ability of Lusianthridin to inhibit lipogenesis was impaired in hepatocytes from β1 S108A knock-in mice and mice bearing a mutation at the AMPK phosphorylation site of acetyl-CoA carboxylase 1/2. Finally, we show that activation of AMPK by natural compounds extends to several analogs of Lusianthridin and the related chemical series, phenanthrenes. The emergence of natural plant compounds that regulate AMPK through the ADaM site raises the distinct possibility that other natural compounds share a common mechanism of regulation.

U2 - 10.1016/j.jbc.2022.101852

DO - 10.1016/j.jbc.2022.101852

M3 - Journal article

C2 - 35331736

AN - SCOPUS:85130402905

VL - 298

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 5

M1 - 101852

ER -

ID: 313869218